-+ 0.00%
-+ 0.00%
-+ 0.00%

Cellution Biologics Inc. Signs Definitive Agreement to Acquire SimpliDerm® Human Hydrated Acellular Dermal Matrix Business from Elutia Inc., Expanding its Allograft Portfolio

Barchart·07/16/2026 15:21:00
Listen to the news

ROSWELL, Ga., July 16, 2026 (GLOBE NEWSWIRE) -- Cellution Biologics Inc., a biologics company focused on developing, manufacturing, and commercializing advanced human tissue-based products for wound care, ocular repair, and other surgical applications, today announced that it has signed a definitive agreement to acquire the SimpliDerm® hydrated human acellular dermal matrix ("ADM") business from Elutia Inc.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.